SCHEMBL18512930

SCHEMBL18512930

CC(C)(CF)NC(=O)c1cc(I)cc(-c2ccc(Cl)cc2)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SHMT1 P34896 1/20 0.36
SHMT2 P34897 1/20 0.36
AKR1C4 P17516 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
SUCNR1 Q9BXA5 2/20 0.35
POLB P06746 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SCN10A Q9Y5Y9 3/20 0.34
CNR1 P21554 2/20 0.34
IKBKB O14920 1/20 0.34
CHUK O15111 1/20 0.34
PPARA Q07869 1/20 0.34
CNR2 P34972 1/20 0.34
GABRA5 P31644 2/20 0.34
SCN2A Q99250 2/20 0.34
ANO1 Q5XXA6 1/20 0.34
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29727644 0.89 L3MBTL1 (0.47) SHMT1SHMT2AKR1C4AKR1C3AKR1C2
SCHEMBL18285345 0.89 L3MBTL1 (0.47) SHMT1SHMT2AKR1C4AKR1C3AKR1C2
SCHEMBL18285279 0.89 CNR2 (0.45) SHMT1SHMT2AKR1C4AKR1C3AKR1C2
SCHEMBL29727678 0.89 CNR2 (0.45) SHMT1SHMT2AKR1C4AKR1C3AKR1C2
SCHEMBL18512933 0.86 SCN10A (0.43) SHMT1SHMT2AKR1C4AKR1C3AKR1C2
SCHEMBL18285294 0.85 CNR1 (0.46) SUCNR1POLBSCN10ACNR1IKBKB
SCHEMBL18285292 0.84 CYP1A2 (0.36) SHMT1SHMT2AKR1C4AKR1C3AKR1C2
SCHEMBL19641940 0.80 MEN1 (0.39) SHMT1SHMT2AKR1C4AKR1C3AKR1C2
SCHEMBL29727624 0.80 MEN1 (0.39) SHMT1SHMT2AKR1C4AKR1C3AKR1C2
SCHEMBL18285322 0.79 SLC6A3 (0.36) SHMT1SHMT2AKR1C4AKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017025523-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2017-02-16 WO disclosed